The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
SP Treon, JJ Castillo, AP Skarbnik… - Blood, The Journal …, 2020 - ashpublications.org
Blood, The Journal of the American Society of Hematology, 2020•ashpublications.org
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
| Blood | American Society of Hematology Skip to Main Content Advertisement Umbrella Alt
Text Umbrella Alt Text Close ASH Clinical News ASH News Daily ASH-SAP Blood Journals
Blood Blood Advances Blood Neoplasia Blood Vessels, Thrombosis & Hemostasis
Hematology The Hematologist International Blood Chinese Edition Blood Japanese Edition
Blood Italian Edition Blood Latin America Edition Blood Spanish Edition ASH ASH Home …
| Blood | American Society of Hematology Skip to Main Content Advertisement Umbrella Alt
Text Umbrella Alt Text Close ASH Clinical News ASH News Daily ASH-SAP Blood Journals
Blood Blood Advances Blood Neoplasia Blood Vessels, Thrombosis & Hemostasis
Hematology The Hematologist International Blood Chinese Edition Blood Japanese Edition
Blood Italian Edition Blood Latin America Edition Blood Spanish Edition ASH ASH Home …
Treon et al provide early clinical data supporting a theoretical rationale for continuing ibrutinib in patients receiving the drug during COVID-19 illness.
ashpublications.org